Xilio Therapeutics, Inc. , a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients.
Xilio Therapeutics stock last closed at $0.82, up 8.38% from the previous day, and has decreased 25.91% in one year. It has overperformed other stocks in the Biotechnology industry by 0.52 percentage points. Xilio Therapeutics stock is currently +31.45% from its 52-week low of $0.62, and -52.06% from its 52-week high of $1.70.
As of Apr 21, 2025, there are 51.77M shares of XLO outstanding. The market cap of XLO is $42.20M. In the past 24 hours, 291,924 XLO shares were traded.
How to Buy Xilio Therapeutics Stock
Not sure how to invest in Xilio Therapeutics stock? Here's how.
Decide where to buy Xilio Therapeutics stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you decide where to buy Xilio Therapeutics stock.
Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Put funds into your investment account: Pick your method of payment and add your info.
Research Xilio Therapeutics stock: The Xilio Therapeutics ticker symbol is XLO. Is Xilio Therapeutics stock a good investment? Should you buy shares of XLO? How do XLO's underlying business fundamentals look? Do top analysts think Xilio Therapeutics is a good buy? Why has XLO's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if XLO is a good stock to buy).
Make your XLO purchase: Decide if you will purchase XLO shares at the current market price or use a limit order to purchase XLO shares at a given price.
Get updates on your investment in XLO: Create a watchlist to key updates about your new investment in Xilio Therapeutics shares.
Step 1: Decide where to buy Xilio Therapeutics stock
You will need a brokerage account in order to access the NASDAQ market and buy XLO stock.
A brokerage account enables you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
We believe that eToro is the best place to buy stocks. eToro gives you:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world financial markets: From Technology to Industrials, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've chosen the right brokerage, it's time to fill out some personal details so you are able to buy XLO stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Xilio Therapeutics stock
Once you have identified the best place to buy Xilio Therapeutics stock, it's important to evaluate their stock prior to investing, so you actually comprehend the risk as well as the opportunity.
Xilio Therapeutics shares at a glance
XLO Price
$0.82
1w %
14.15%
1y %
-25.91%
5y %
N/A
P/E
-0.75x
P/B
2.4x
P/S
6.85x
PEG
N/A
Revenue
$6.34M
Earnings
-$58.24M
Fore. Rev. Growth
99.12%
Fore. Earn. Growth
N/A
Market Cap
$42.20M
Next Earnings
Jun 13, 2025
Next Dividend
N/A
Xilio Therapeutics Fundamentals
WallStreetZen was created to help average investors perform better fundamental analysis.
You can see all of the due diligence checks on XLO's stock page.
Is XLO stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge XLO's fair value.
Using relative valuations methods:
XLO may be undervalued based on its P/B ratio of 2.4x, relative to Biotechnology industry P/B ratio of 4.04x
No, Xilio Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about XLO
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your XLO purchase
You have two main options:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are generally the easiest way to buy.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at a given dollar amount, use a limit order.
Hit the Open button and your broker will place your order.
If you want additional help buying stocks on eToro, click the helpful video below:
How much does it cost to buy one Xilio Therapeutics share?
As of Apr 21, 2025, it costs $0.82 to buy one share of Xilio Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.41, you can buy 0.5 shares of XLO.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.